Meta-analysis
Open access
Sep 2026
Sarcopenia and Survival in Patients With Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Analysis of Prognostic Association
Sarcopenia, characterized by loss of skeletal muscle mass and function, has emerged as a potential prognostic biomarker in oncology. Its role in patients with head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) remains inadequately defined.
D. Koirala, Nakendra Malla, Bivek Mishra et al.
· Cancer Reports · 0 citations